PCT/US2013/039561
STABLE FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES
Details for PCT/US2013/039561
Dates
Deadlines
Abstract
Info
PCT Patent application PCT/US2013/039561 was filed on May 3, 2013 by AMGEN INC.. The title of this PCT Patent Application is "STABLE FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES" and the patent specification was published as WO/2013/166448 on November 7, 2013.
The earliest priority date for the patent application is May 3, 2012 and therefore the 30 month national phase deadline for PCT/US/2013/039561 is November 3, 2014 and the 31 month national phase deadline for PCT/US/2013/039561 is December 3, 2014
Legal
The information provided herein is not legal or other professional advice. The information herein may be provided from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein.